Simris Group AB OMXSTO:SIMRIS_B:
ANNOUNCES LEADERSHIP TRANSITION
DANIEL KUBITZA APPOINTED INTERIM CEO
Simris Group Appoints Interim CEO
Earlier from Simris
- Simris Announces Positive Results From Study With Nuvisan
- SIMRIS_B: EBITDA loss narrowed 51% in Q2, but liquidity remains a critical concern
- SIMRIS_B: Revenue plunged, losses narrowed, and urgent funding is needed for continued operations
- SIMRIS_B: Simris Group pivots to biopharma but faces urgent liquidity challenges and going concern risks
- SIMRIS_B: Revenue up, losses narrowed, but urgent funding needed amid leadership and strategic shifts
Later from Simris
- SIMRIS_B: Revenue fell sharply and funding is urgent despite operational improvements and R&D progress
- Simris Group Enters Into Bridge Loan Agreement
- Simris Group AB (publ) receives notice of conversion of convertible bonds
- Bulletin from Simris Group AB’s extraordinary general meeting
- SIMRIS_B: Losses narrowed in 2025, but continued operations depend on securing new financing
Follow Simris into a list and get an email when it puts out news.
Follow Simris